@article{0b2d351d03094ffea6a6125de7fecde9,
title = "Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity",
keywords = "predictive tumor markers, carcinoma, non-small cell lung, molecular targeted therapy, molecular pathology, precision medicine, CIRCULATING TUMOR DNA, OF-AMERICAN-PATHOLOGISTS, SYSTEMIC TREATMENT, EXPERT OPINION, DIAGNOSTICS, QUALITY, PD-L1, NSCLC, RECOMMENDATIONS, ONCOLOGY",
author = "{van den Broek}, Daan and Hiltermann, {T. Jeroen N.} and Bonne Biesma and Dinjens, {Winand N. M.} and {'t Hart}, {Nils A.} and Hinrichs, {John W. J.} and Leers, {Mathie P. G.} and Kim Monkhorst and {van Oosterhout}, Matthijs and Volkher Scharnhorst and Ed Schuuring and Speel, {Ernst-Jan M.} and {van den Heuvel}, {Michel M.} and {van Schaik}, {Ron H. N.} and {von der Thusen}, Jan and Willems, {Stefan M.} and {de Visser}, Leonie and Ligtenberg, {Marjolijn J. L.}",
year = "2020",
month = jan,
day = "22",
doi = "10.3389/fonc.2019.01521",
language = "English",
volume = "9",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S.A.",
}